Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

Completed

• Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)

• Registration Number: NCT00711724
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-07
• Study First Submitted: 2008-07-03
• Study First Submitted QC: 2008-07-03
• Study First Posted: 2008-07-09
• Primary Completion: 2009-03
• Study Completion: 2009-03
• Status Verified: 2010-06
• Last Update Submitted: 2010-06-21
• Last Update Posted: 2010-06-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Diagnosis of ADHD
• Age 13-65* *Parental consent and patient's assent will be obtained for minors participating in this protocol (only adolescents aged 13-18 yrs old will be included in the MGH site)

Exclusion Criteria

• Inability to reliably report ADHD symptoms at the discretion of the investigator

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The ADHD-RS and ASRS v1.1 Symptom Checklist scales	Weeks 1, 2, 3, 4, 5, 6, 7, or 8

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Cambridge, Massachusetts, United States